Cor van den Bos

4.9k total citations · 1 hit paper
93 papers, 3.1k citations indexed

About

Cor van den Bos is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Cor van den Bos has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pediatrics, Perinatology and Child Health, 33 papers in Public Health, Environmental and Occupational Health and 18 papers in Hematology. Recurrent topics in Cor van den Bos's work include Childhood Cancer Survivors' Quality of Life (47 papers), Acute Lymphoblastic Leukemia research (31 papers) and Histiocytic Disorders and Treatments (14 papers). Cor van den Bos is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (47 papers), Acute Lymphoblastic Leukemia research (31 papers) and Histiocytic Disorders and Treatments (14 papers). Cor van den Bos collaborates with scholars based in Netherlands, United States and Canada. Cor van den Bos's co-authors include N.E. Langeveld, Rob Pieters, Leontien C.M. Kremer, Helena J. H. van der Pal, Martha A. Grootenhuis, Huib N. Caron, Rob J. de Haan, P.A. Voûte, Monique Jaspers and Caro C.E. Koning and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Cor van den Bos

90 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer

2007 597 citations Cor van den Bos, Monique Jaspers et al. profile →

Peers

Cor van den Bos

PPCH

PHEOH

ONCOL

PHYSI

SPS

Wassim Chemaitilly United States

Todd M. Gibson United States

Lillian R. Meacham United States

Sharon M. Castellino United States

Lars Hjorth Sweden

Liton Francisco United States

Eline van Dulmen‐den Broeder Netherlands

Päivi M. Lähteenmäki Finland

Helena J. H. van der Pal Netherlands

Inge M. van der Sluis Netherlands

Wassim Chemaitilly United States

Cor van den Bos

2.7k ×1.7

PPCH

1.9k ×1.6

PHEOH

657 ×1.2

ONCOL

335 ×0.8

PHYSI

510 ×1.3

SPS

Citations per year, relative to Cor van den Bos Cor van den Bos (= 1×) peers Wassim Chemaitilly

Countries citing papers authored by Cor van den Bos

Since Specialization

Citations

This map shows the geographic impact of Cor van den Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cor van den Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cor van den Bos more than expected).

Fields of papers citing papers by Cor van den Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cor van den Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cor van den Bos. The network helps show where Cor van den Bos may publish in the future.

Co-authorship network of co-authors of Cor van den Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Cor van den Bos. A scholar is included among the top collaborators of Cor van den Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cor van den Bos. Cor van den Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halteren, Astrid G. S. van, Paul G. Kemps, Yanling Xiao, et al.. (2025). Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms. PubMed. 2(2). 100074–100074. 1 indexed citations

Donadieu, Jean, D. A. Evseev, Caroline Hutter, et al.. (2025). Long-term off-label MAPK inhibitor therapy in children with severe/refractory Langerhans cell histiocytosis: An international observational study of 277 cases.. Journal of Clinical Oncology. 43(16_suppl). 10011–10011.

Milne, Paul, Aurora Chinnici, Maria Luisa Coniglio, et al.. (2024). Prognostic Value of BRAFV600E in Peripheral Blood of Children with Langerhans Cell Histiocytosis: A Multicenter Project of the European Consortium for Histiocytosis. Blood. 144(Supplement 1). 3908–3908. 1 indexed citations

Kemps, Paul G., Lennart Kester, Marijn A. Vermeulen, et al.. (2024). Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms. Histopathology. 84(5). 837–846. 4 indexed citations

Bos, Cor van den, Miranda P. Dierselhuis, Marta Fiocco, et al.. (2023). Thyroid Profile in the First Three Months after Starting Treatment in Children with Newly Diagnosed Cancer. Cancers. 15(5). 1500–1500. 2 indexed citations

Steur, Lindsay M. H., Reinoud J. B. J. Gemke, Natasha K. A. van Eijkelenburg, et al.. (2023). Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands. BMJ Open. 13(10). e070804–e070804. 4 indexed citations

Montfrans, Joris van, Samuel A. Merrill, Lisette van de Corput, et al.. (2021). A Minimal Parameter Set Facilitating Early Decision-making in the Diagnosis of Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 41(6). 1219–1228. 9 indexed citations

Steur, Lindsay M. H., Martha A. Grootenhuis, Eus J.W. Van Someren, et al.. (2020). High prevalence of parent‐reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy. Pediatric Blood & Cancer. 67(4). e28165–e28165. 26 indexed citations

Steur, Lindsay M. H., Gertjan J.L. Kaspers, Eus J.W. Van Someren, et al.. (2019). Sleep–wake rhythm disruption is associated with cancer-related fatigue in pediatric acute lymphoblastic leukemia. SLEEP. 43(6). 26 indexed citations

10.

Mathôt, Ron A. A., Rob Pieters, Válerie de Haas, et al.. (2019). Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients. Clinical Infectious Diseases. 71(8). e281–e288. 5 indexed citations

11.

Kraal, Kathelijne C.J.M., Ilse Timmerman, Cor van den Bos, et al.. (2018). Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution. Clinical Cancer Research. 25(3). 1012–1021. 5 indexed citations

12.

Mathôt, Ron A. A., Rob Pieters, Válerie de Haas, et al.. (2016). Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients. Haematologica. 102(3). 552–561. 16 indexed citations

13.

Donadieu, Jean, Frédéric Bernard, Max M. van Noesel, et al.. (2015). Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. Blood. 126(12). 1415–1423. 90 indexed citations

14.

Tong, Wing H., Rob Pieters, Gertjan J.L. Kaspers, et al.. (2014). A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood. 123(13). 2026–2033. 155 indexed citations

15.

Hartman, Annelies, et al.. (2006). No adverse effect of vincristine on handwriting in children after completion of therapy. Pediatric Blood & Cancer. 49(6). 841–845. 8 indexed citations

16.

Hartman, Annelies, Cor van den Bos, Theo Stijnen, & Rob Pieters. (2006). Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine. Cancer. 106(6). 1395–1401. 66 indexed citations

17.

Bos, Cor van den. (2002). Tumors of the Pediatric Central Nervous System. Annals of Oncology. 13(2). 335–335. 17 indexed citations

18.

Jaspers, Monique, Cor van den Bos, & Hubert Caron. (2001). A National Late Cancer Treatment Effects Registry in the Netherlands: LATER. Europe PMC (PubMed Central). 934–934. 1 indexed citations

19.

Bos, Cor van den, et al.. (2000). Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia. Medical and Pediatric Oncology. 34(4). 278–280. 4 indexed citations

20.

Bos, Cor van den, et al.. (1992). Flow cytometric analysis of peripheral blood erythrocyte chimerism in α‐thalassemic mice. Cytometry. 13(6). 659–662. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact